JP2019520042A - 細菌感染及びウイルス感染を診断するための方法 - Google Patents

細菌感染及びウイルス感染を診断するための方法 Download PDF

Info

Publication number
JP2019520042A
JP2019520042A JP2018556471A JP2018556471A JP2019520042A JP 2019520042 A JP2019520042 A JP 2019520042A JP 2018556471 A JP2018556471 A JP 2018556471A JP 2018556471 A JP2018556471 A JP 2018556471A JP 2019520042 A JP2019520042 A JP 2019520042A
Authority
JP
Japan
Prior art keywords
patient
bacterial
biomarkers
viral
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2018556471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520042A5 (https=
Inventor
ピューベシュ カトリ，
ピューベシュ カトリ，
ティモシー イー． スウィーニー，
ティモシー イー． スウィーニー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of JP2019520042A publication Critical patent/JP2019520042A/ja
Publication of JP2019520042A5 publication Critical patent/JP2019520042A5/ja
Priority to JP2023061560A priority Critical patent/JP7750895B2/ja
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2018556471A 2016-06-07 2017-06-05 細菌感染及びウイルス感染を診断するための方法 Ceased JP2019520042A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023061560A JP7750895B2 (ja) 2016-06-07 2023-04-05 細菌感染及びウイルス感染を診断するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662346962P 2016-06-07 2016-06-07
US62/346,962 2016-06-07
PCT/US2017/036003 WO2017214061A1 (en) 2016-06-07 2017-06-05 Methods for diagnosis of bacterial and viral infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023061560A Division JP7750895B2 (ja) 2016-06-07 2023-04-05 細菌感染及びウイルス感染を診断するための方法

Publications (2)

Publication Number Publication Date
JP2019520042A true JP2019520042A (ja) 2019-07-18
JP2019520042A5 JP2019520042A5 (https=) 2020-07-16

Family

ID=60578903

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018556471A Ceased JP2019520042A (ja) 2016-06-07 2017-06-05 細菌感染及びウイルス感染を診断するための方法
JP2023061560A Active JP7750895B2 (ja) 2016-06-07 2023-04-05 細菌感染及びウイルス感染を診断するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023061560A Active JP7750895B2 (ja) 2016-06-07 2023-04-05 細菌感染及びウイルス感染を診断するための方法

Country Status (11)

Country Link
US (2) US11274345B2 (https=)
EP (1) EP3464645A4 (https=)
JP (2) JP2019520042A (https=)
KR (3) KR20230049750A (https=)
CN (1) CN109312411A (https=)
AU (2) AU2017278254A1 (https=)
BR (1) BR112018075288A2 (https=)
CA (1) CA3022616A1 (https=)
IL (2) IL312537B2 (https=)
MX (2) MX2018015184A (https=)
WO (1) WO2017214061A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021193853A1 (https=) * 2020-03-27 2021-09-30
JPWO2022045126A1 (https=) * 2020-08-25 2022-03-03

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019227186B2 (en) 2018-02-27 2025-07-10 The Board Of Trustees Of The Leland Stanford Junior University Classifier for identification of robust sepsis subtypes
GB201806052D0 (en) 2018-04-12 2018-05-30 Univ Liverpool Detection of bacterial infections
WO2019217296A1 (en) * 2018-05-07 2019-11-14 Yale University Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
CN113195738B (zh) 2018-08-04 2025-01-28 帝国理工学院创新有限公司 识别患有川崎病的受试者的方法
CN112639122A (zh) * 2018-09-19 2021-04-09 英芙勒玛提克斯公司 利用等温扩增和相对丰度评估宿主rna
US11369318B2 (en) 2019-05-31 2022-06-28 Light Ai, Inc. Image processing of streptococcal infection in pharyngitis subjects
EP3864669B1 (en) 2018-10-09 2024-12-04 Light AI Inc. Image processing of streptococcal infection in pharyngitis subjects
US20220267865A1 (en) * 2019-02-05 2022-08-25 Universidade De Santiago De Compostela In vitro method for the diagnosis of viral infections
AU2020244763A1 (en) * 2019-03-22 2021-09-30 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
WO2020197659A1 (en) 2019-03-25 2020-10-01 The Board Of Trustees Of The Leland Stanford Junior University Signature for diagnosis of bacterial vs viral infections
US11104946B2 (en) * 2019-04-23 2021-08-31 Inflammatix, Inc. DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome
CN110082338A (zh) * 2019-05-15 2019-08-02 广西科技大学 超顺磁性Fe3O4@SiO2@Ag纳米复合材料用于对苯唑西林SERS检测的方法
EP3817005A1 (en) * 2019-11-01 2021-05-05 Koninklijke Philips N.V. System for infection diagnosis
AU2020382701A1 (en) * 2019-11-13 2022-06-02 The Regents Of The University Of Colorado A Body Corporate Identification of host RNA biomarkers of infection
IL293728A (en) 2019-12-11 2022-08-01 Ichilov Tech Ltd Non-invasive assay for differentiating between bacterial and viral infections
EP4629189A3 (en) 2020-03-19 2025-12-24 Light AI Inc. Infection detection using image data analysis
KR102422238B1 (ko) * 2020-04-27 2022-07-18 경북대학교 산학협력단 TGFBIp의 아세틸화 수준을 측정하는 제제를 포함하는 중증급성호흡기증후군 바이러스 2 진단용 조성물
WO2021221863A1 (en) * 2020-04-28 2021-11-04 Heeger, Brandon Rapid testing mechanism and method for respiratory viral pathogens
CN111848772B (zh) * 2020-08-03 2022-03-18 山东绿都生物科技有限公司 SAMD9突变型蛋白、Vero细胞系及其构建方法和应用
EP4308729B1 (en) * 2021-03-16 2025-10-29 Cepheid Methods for discriminating bacterial and viral infections in a human subject
WO2022235765A2 (en) * 2021-05-04 2022-11-10 Inflammatix, Inc. Systems and methods for assessing a bacterial or viral status of a sample
CN115029426B (zh) * 2022-04-19 2025-05-27 武汉大学中南医院 冠心病诊断剂及dysf基因甲基化在制备冠心病诊断剂中的应用
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate
WO2025059317A1 (en) * 2023-09-13 2025-03-20 President And Fellows Of Harvard College Transcriptomic signatures for identifying drug-susceptible mycobacterium tuberculosis complex
KR102951592B1 (ko) 2023-11-21 2026-04-14 바디텍메드(주) 믹소바이러스 내성 단백질 a와 c-반응성 단백질을 이용한 박테리아감염과 바이러스감염 구별을 위한 진단 시스템
CN118127149B (zh) * 2024-05-10 2024-07-09 天津云检医学检验所有限公司 一种用于评估受试者的败血症风险和感染型的生物标志物、模型及试剂盒
CN119479830B (zh) * 2025-01-15 2025-05-16 北京大学 一种多中心数据聚合方法
CN121380333B (zh) * 2025-12-20 2026-04-21 广东辉锦创兴生物医学科技有限公司 通过检测宿主外周血基因表达鉴别待测样品感染类别的试剂盒及其方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110275542A1 (en) * 2010-04-21 2011-11-10 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
JP2015510122A (ja) * 2012-02-09 2015-04-02 メメド ダイアグノスティクス リミテッド 感染を診断するための特徴および決定因子ならびにその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040038201A1 (en) 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
WO2007059119A2 (en) * 2005-11-11 2007-05-24 Ivan Borozan Systems and methods for identifying diagnostic indicators
NZ573052A (en) 2006-04-26 2012-03-30 Vertex Pharma Hepatitis c virus infection biomarkers
WO2012012693A2 (en) * 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
GB201201766D0 (en) * 2012-02-01 2012-03-14 Imp Innovations Ltd Method
WO2013162651A1 (en) 2012-04-28 2013-10-31 Us Army Center For Environmental Health Research(Cehr) Biomarkers of immune dysfunction in response to chronic stress, methods of use and diagnostic kits
EP2847354A4 (en) * 2012-05-08 2015-12-30 Univ Leland Stanford Junior METHOD AND COMPOSITIONS FOR ASSESSING A PRE-DECLAMPSY
CN109504768A (zh) * 2013-03-15 2019-03-22 威拉赛特公司 用于诊断肺病的生物标记物及其使用方法
US20160244834A1 (en) * 2013-06-28 2016-08-25 Acumen Research Laboratories Pte. Ltd. Sepsis biomarkers and uses thereof
JP2016530545A (ja) * 2013-09-17 2016-09-29 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 卵巣がんに関するバイオマーカー
WO2015048098A1 (en) * 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
GB201406259D0 (en) 2014-04-07 2014-05-21 Univ Edinburgh Molecular predictors of neonatal sepsis
EP3221340B1 (en) * 2014-11-19 2024-05-22 P & M Venge AB Diagnostic method employing human neutrophil lipocalin (hnl)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110275542A1 (en) * 2010-04-21 2011-11-10 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
JP2015510122A (ja) * 2012-02-09 2015-04-02 メメド ダイアグノスティクス リミテッド 感染を診断するための特徴および決定因子ならびにその使用方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SWEENEY, T. E. ET AL., SCIENCE TRANSLATIONAL MEDICINE, vol. 7, no. 287, JPN6021012057, 2015, pages 1 - 15, ISSN: 0004931184 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021193853A1 (https=) * 2020-03-27 2021-09-30
WO2021193853A1 (ja) * 2020-03-27 2021-09-30 株式会社島津製作所 新型コロナウイルスの検査方法および検査試薬
WO2021192370A1 (ja) * 2020-03-27 2021-09-30 株式会社島津製作所 新型コロナウイルスの検査方法および検査試薬
JPWO2022045126A1 (https=) * 2020-08-25 2022-03-03
WO2022045126A1 (ja) * 2020-08-25 2022-03-03 学校法人 久留米大学 ウイルス感染の判定方法
JP7748105B2 (ja) 2020-08-25 2025-10-02 学校法人 久留米大学 ウイルス感染の判定方法

Also Published As

Publication number Publication date
MX2024009339A (es) 2024-08-09
KR20230049750A (ko) 2023-04-13
IL312537B2 (en) 2026-01-01
CA3022616A1 (en) 2017-12-14
JP2023098945A (ja) 2023-07-11
KR102915694B1 (ko) 2026-01-20
AU2017278254A1 (en) 2018-11-15
IL312537B1 (en) 2025-09-01
KR20190015294A (ko) 2019-02-13
BR112018075288A2 (pt) 2019-03-19
IL262762A (en) 2018-12-31
IL262762B2 (en) 2024-10-01
EP3464645A4 (en) 2020-05-06
CN109312411A (zh) 2019-02-05
AU2023226757A1 (en) 2023-09-28
MX2018015184A (es) 2019-04-24
KR102515555B1 (ko) 2023-03-28
US20190144943A1 (en) 2019-05-16
EP3464645A1 (en) 2019-04-10
US20220127673A1 (en) 2022-04-28
IL312537A (en) 2024-07-01
KR20240100488A (ko) 2024-07-01
IL262762B1 (en) 2024-06-01
WO2017214061A1 (en) 2017-12-14
JP7750895B2 (ja) 2025-10-07
US11274345B2 (en) 2022-03-15

Similar Documents

Publication Publication Date Title
JP7750895B2 (ja) 細菌感染及びウイルス感染を診断するための方法
US12473597B2 (en) Methods and systems for processing a nucleic acid sample
JP2023138990A (ja) 敗血症の診断法
US20240011096A1 (en) Biomarkers for use in prognosis of mortality in critically ill patients
EP4334474A2 (en) Systems and methods for assessing a bacterial or viral status of a sample
CA3001134A1 (en) Methods for diagnosis of tuberculosis
AU2017315328A1 (en) Systemic inflammatory and pathogen biomarkers and uses therefor
EP3394291B1 (en) Triage biomarkers and uses therefor
WO2020096796A1 (en) Method for predicting severe dengue
WO2023073392A1 (en) Biomarkers and uses therefor

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20190913

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200602

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200602

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210406

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210706

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211006

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220308

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220608

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230216

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230307

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20230725